Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-05-31

Clinical Trial Update: Intravenous Tranexamic Acid During Rhytidectomy [Phase 4]

View source ↗

Summary

Phase 4 trial updating intravenous tranexamic acid use during rhytidectomy to address bleeding and bruising in facial procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intravenous tranexamic acid (tranexamic acid)

Snippet

Sponsor: Glasgold Group Plastic Surgery | Conditions: Bleeding, Bruising Face | Phase 4 | Status: UNKNOWN